Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
This symposium is designed to educate health care providers on the revolutionary ways that next-generation genetic sequencing is advancing patient care in cancer genetics. Over the past year the field of oncology has rapidly evolved to include both multi-gene, germline genetic testing as well as genetic profiling of tumor cells, allowing practitioners to tailor treatment, management, and screening to the individual patient. Moreover, the adoption and implementation of these novel genetic services will require a multilevel effort that includes education of providers and administrators to avoid potential pitfalls, such as inappropriate testing and/or increased patient anxiety. The ability of health care providers to gather an accurate family history is now more important than ever to identifying patients as candidates for the ever expanding array of cancer genetic tests. Through both lectures and case presentations we will illustrate both the value and application of next generation genetic sequencing technologies, allowing attendees to advance their own clinical care.
At the completion of this symposium, attendees should be better able to:
Health care providers including medical oncology, surgical oncology, radiation oncology, gynecologic oncology, gastrointestinal oncology, ob-gyn, genetic counselors, primary care physicians and nurses/nurse practitioners who are involved and/or interested in cancer genetics.
5:15 - 6:00pm Registration/Dinner Service
6:00 - 6:10pm Introduction and Overview
Deborah Toppmeyer, MD
6:10 - 7:00pm Keynote Presentation: Multigene Testing in Oncology
Mark Robson, MD
7:00 - 7:45pm Tumor Profiling Case Presentation
Shridar Ganesan, MD, PhD
Kim Hirshfield, MD, PhD
Hetal Vig, MS, CGC
7:45 - 8:15pm Germline Testing Case Presentation
Angela Fay, MS, CGC
Jayne Murphy, MS, CGC
Sandra Mento, MS, CGC
Sarah Nashed, MS, CGC
Stephanie Pachter, MS, CGC
8:15 - 8:30pm Discussion and Questions
This symposium is provided by Rutgers Cancer Institute of New Jersey and the Center for Continuing and Outreach Education at Rutgers Biomedical and Health Sciences in collaboration with Meridian Health.
Support for this symposium is provided by The Val Skinner Foundation.